gms | German Medical Science

72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

06.06. - 09.06.2021

Glycation of benign meningioma cells leads to an increased malignant potential

Glykierung von beningnen Meningeomzellen führt zu einem aggressiveren Verhalten

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Maximilian Scheer - Universitätsklinikum Halle, Klinik mit Poliklinik für Neurochirurgie, Halle/Saale, Deutschland
  • Philipp Selke - Martin-Luther-Universität Halle-Wittenberg, Institut für Physiologische Chemie, Halle/Saale, Deutschland
  • Rüdiger Horstkorte - Martin-Luther-Universität Halle-Wittenberg, Institut für Physiologische Chemie, Halle/Saale, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie. sine loco [digital], 06.-09.06.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocV087

doi: 10.3205/21dgnc086, urn:nbn:de:0183-21dgnc0869

Veröffentlicht: 4. Juni 2021

© 2021 Scheer et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: In a previous study, we investigated the influence of glycation in invasiveness on two meningioma cell lines representing the WHO grade I and III. Therefore cells were treated with Methylglyoxal (MGO). We could show, that glycation leads to a more aggressive behavior of the beningn cell line and to a less aggressive behavior of the malignant cell line. In this study, we wanted to investigate the molecular mechanisms of this behaviour.

Methods: Two meningioma cell lines, representing the WHO grade I (BEN-MEN-1) and the WHO grade III (IOMM-Lee) were cultured in the absence or presence of MGO. Expression of N-Cadherin, E-Cadherin, several Integrins, RAGE (Receptor for Advanced Glycation Endproducts), NCAM (neuronal cell adhesion molecul), Tn-Antigen and GALNT (GalNAc polypeptide N-acetylgalactosaminyltransferases) were analyzed.

Results: We observed that E-Cadherin expression was increased after glycation and N-Cadherin expression was decreased in BEN-MEN-1 cells. The Cadherin expression was not affected in IOMM-Lee cells. In both cell lines, we could observe an increased RAGE expression after glycation. Tn-Antigen was increased after glycation in BEN-MEN1 cells and was not affected in IOM-LEE cells after glycation. The expression of NCAM was decreases in IOM-LEE cells after glycation. For the GALNT 10 we saw no alteration in IOM-LEE cells after glycation where it was decreased in BEN-MEN1 cells.

Conclusion: Glycation of benign meningioma cell line results in an increased E-Cadherin and RAGE expression and a decreased N-Cadherin expression, which could be an evidence for more invasiveness of the benign meningioma cell line. IOMM-Lee cells were not affected in Cadherin expression through glycation. In addition, we saw changes in the expression of Tn-Antigen and GALNT 10 in BEN-MEN1 cells after glycation.

Figure 1 [Fig. 1], Figure 2 [Fig. 2]